News Overview

Bottneuro AG


Bottneuro aims to become a leading provider of diagnosis and personalized neuromodulation therapies for early stage patients suffering from Alzheimer’s disease.

You may also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.